Expression of PEA3 and Lack of Correlation Between PEA3 and HER-2/neu Expression in Breast Cancer
Aysegul Sahin
Breast Cancer Research and Treatment, 2006
View PDFchevron_right
The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis
John Hassell, William Muller
Current Biology, 2001
View PDFchevron_right
The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase
John Hassell
Oncogene, 1998
View PDFchevron_right
Expression of HER2 in Breast Cancer Promotes a Massive Reorganization of Gene Activity and Suggests a Role for Epigenetic Regulation
Michael McClelland
Journal of data mining in genomics & proteomics, 2012
View PDFchevron_right
Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression
Rosette Lidereau
Carcinogenesis, 2003
View PDFchevron_right
Identification and Characterization of PEA3 Ets Subfamily Target Genes in Human Mammary Epithelial Cells
John Hassell
2003
View PDFchevron_right
Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1
Gabrielle Kelly
Journal of Clinical Pathology, 2004
View PDFchevron_right
Biologic and therapeutic role of HER2 in cancer
Elda Tagliabue
Oncogene, 2003
View PDFchevron_right
Expression of HER2 and its association with AP-2 in breast cancer
Anita Naukkarinen
European Journal of Cancer, 2004
View PDFchevron_right
Protein Kinase C Determines HER2 Fate in Breast Carcinoma Cells with HER2 Protein Overexpression without Gene Amplification
Lidia Albano, Elda Tagliabue
Cancer Research, 2007
View PDFchevron_right
ETS genes in breast cancer: A step in the right direction
Saraswati Sukumar
Cancer Biology & Therapy, 2007
View PDFchevron_right
HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer
P. Casalini, Elda Tagliabue
Annals of Oncology, 2001
View PDFchevron_right
Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis
John Hassell
Journal of mammary gland biology and neoplasia, 2003
View PDFchevron_right
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
Joaquín Arribas
Oncogene, 2011
View PDFchevron_right
ONCOLOGIA E PATOLOGIA SPERIMENTALE XXIX Ciclo DEVELOPMENT OF PRECLINICAL MODELS OF MAMMARY CARCINOGENESIS: FUNCTIONAL ROLE OF HER2 AND ITS ISOFORMS IN TUMOR PROGRESSION AND IN DRUG RESISTANCE
roberta Laranga
View PDFchevron_right
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
Jörgen Carlsson
British journal of cancer, 2004
View PDFchevron_right
Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited
Ruth Lupu
2007
View PDFchevron_right
Expression of the HER 1-4 family of receptor tyrosine kinases in breast cancer. Commentary
William Gullick
Journal of Pathology, 2003
View PDFchevron_right
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients
Rupert Bartsch
Breast (Edinburgh, Scotland), 2014
View PDFchevron_right
Supplementary Figure 3 from HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation
christian young
View PDFchevron_right
PIK3CA, KI67, Estrogen (ER) and Progesterone Receptors (PR) Expression Pattern of in HER2 Positive Breast Cancers
onyekachi onu
Asian Pacific Journal of Cancer Biology
View PDFchevron_right
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
Martyn Caplin
The Journal of Pathology, 2003
View PDFchevron_right
A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
Thinh Pham
Cancer Research, 2008
View PDFchevron_right
Standardized Assessment of the HER2 Status in Breast Cancer by Immunohistochemistry
Linda Schiffhauer
Laboratory Medicine, 2011
View PDFchevron_right
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
Lance Liotta
Clinical Cancer Research, 2012
View PDFchevron_right
The HER2 Signaling Network in Breast Cancer-Like a Spider in its Web
Anna-Lena Dittrich
Journal of mammary gland biology and neoplasia, 2014
View PDFchevron_right
HER-2 Signaling in Human Breast Cancer
Kathleen Ignatoski
Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways, 2011
View PDFchevron_right
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
Alexander Gorelick
Cancer Discovery
View PDFchevron_right
Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ER - breast cancer
Francisco Esteva
Proceedings of the National Academy of Sciences, 2012
View PDFchevron_right
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer
Synnöve Staff
BMC Cancer
View PDFchevron_right
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Ivana Sestak
Breast Cancer Research, 2012
View PDFchevron_right
Supplementary Figure 2 from HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation
christian young
View PDFchevron_right
HER-2 in breast cancer—methods of detection, clinical significance and future prospects for treatment
Sarah Pinder
Critical Reviews in Oncology Hematology, 2002
View PDFchevron_right
A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis
Santiago Ramón y Cajal
Molecular and Cellular Biology, 2009
View PDFchevron_right